Advertisement

Current Neurology and Neuroscience Reports

, Volume 3, Issue 3, pp 256–264 | Cite as

Postinfectious encephalomyelitis

  • Dean M. Wingerchuk
Article

Abstract

Postinfectious forms of encephalomyelitis, also termed acute disseminated encephalomyelitis (ADEM), form one of several categories of inflammatory demyelinating disorders of the central nervous system (CNS). Recent large, retrospective case series have refined our understanding of the clinical, laboratory, and neuroimaging characteristics of ADEM. The differences between childhood and adult ADEM, risks of development of multiple sclerosis, and the contributions of recent studies to refining the nosology of CNS demyelinating syndromes are discussed.

Keywords

Multiple Sclerosis Experimental Autoimmune Encephalomyelitis Encephalomyelitis Optic Neuritis Brain Magnetic Resonance Imaging 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Dale RC, de Sousa C, Chong WK, et al.: Acute disseminated encephalomyelitis, multiphasic encephalomyelitis and multiple sclerosis in children. Brain 2000, 123:2407–2422. Large, contemporary comparison of children with acute disseminated encephalomyelitis, multiphasic encephalomyelitis, and multiple sclerosis and mean follow-up of nearly 6 years.PubMedCrossRefGoogle Scholar
  2. 2.
    Hynson JL, Kornberg AJ, Coleman LT, et al.: Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology 2001, 56:1308–1312. Retrospective review notes some general differences at presentation between cases that eventually are diagnosed as acute disseminated encephalomyelitis and multiple sclerosis.PubMedGoogle Scholar
  3. 3.
    Murthy SN, Faden HS, Cohen ME, Bakshi R: Acute disseminated encephalomyelitis in children. Pediatrics 2002, 110:e21. This smaller series utilized more strict diagnostic criteria and provides detailed magnetic resonance imaging results.PubMedCrossRefGoogle Scholar
  4. 4.
    Schwarz S, Mohr A, Knauth M, et al.: Acute disseminated encephalomyelitis. A follow-up study of 40 adult patients. Neurology 2001, 56:1313–1318. This is the largest modern series of adults presenting with acute disseminated encephalomyelitis.PubMedGoogle Scholar
  5. 5.
    Tenembaum S, Chamoles N, Fejerman N: Acute disseminated encephalomyelitis. A long-term follow-up study of 84 pediatric patients. Neurology 2002, 59:1224–1231. This large, prospective series of childhood acute disseminated encephalomyelitis provides more than 6 years of mean follow-up data and emphasizes a generally good prognosis.PubMedGoogle Scholar
  6. 6.
    Bhigjee AI, Patel VB, Bhagwan B, et al.: HIV and acute disseminated encephalomyelitis. S Afr Med J 1999, 89:283–284.PubMedGoogle Scholar
  7. 7.
    Narisco P, Galgani S, Del Grosso B, et al.: Acute disseminated encephalomyelitis as manifestation of primary HIV infection. Neurology 2001, 57:1493–1496.Google Scholar
  8. 8.
    Tachi N, Watanabe T, Wakai S, et al.: Acute disseminated encephalomyelitis following HTLV-1 associated myelopathy. J Neurol Sci 1992, 110:234–235.PubMedCrossRefGoogle Scholar
  9. 9.
    Sacconi S, Salviati L, Merelli E: Acute disseminated encephalomyelitis associated with hepatitis C virus infection. Arch Neurol 2001, 58:1679–1681.PubMedCrossRefGoogle Scholar
  10. 10.
    Spieker S, Petersen D, Rolfs A, et al.: Acute disseminated encephalomyelitis following Pontiac fever. Eur Neurol 1998, 40:169–172.PubMedCrossRefGoogle Scholar
  11. 11.
    Heick A, Skriver E: Chlamydia pneumoniae-associated ADEM. Eur J Neurol 2000, 7:435–438.PubMedCrossRefGoogle Scholar
  12. 12.
    Sommer JB, Erbguth FJ, Neundorfer B: Acute disseminated encephalomyelitis following Legionella pneumophila infection. Eur Neurol 2000, 44:182–184.PubMedCrossRefGoogle Scholar
  13. 13.
    Dodick DW, Silber MH, Noseworthy JH, et al.: Acute disseminated encephalomyelitis after accidental injection of a hog vaccine: successful treatment with plasmapheresis. Mayo Clin Proc 1998, 73:1193–1195.PubMedGoogle Scholar
  14. 14.
    Patel SP, Friedman RS: Neuropsychiatric features of acute disseminated encephalomyelitis: a review. J Neuropsychiatr Clin Neurosci 1997, 9:534–540.Google Scholar
  15. 15.
    Moscovich DG, Singh MB, Eva FJ, Puri BK: Acute disseminated encephalomyelitis presenting as an acute psychotic state. J Nerv Ment Dis 1995, 183:116–117.PubMedCrossRefGoogle Scholar
  16. 16.
    Wang PN, Fuh JL, Liu HC, Wang SJ: Acute disseminated encephalomyelitis in middle-aged or elderly patients. Eur Neurol 1996, 36:219–223.PubMedGoogle Scholar
  17. 17.
    Nasr JT, Andriola MR, Coyle PK: ADEM: Literature review and case report of acute psychosis presentation. Pediatr Neurol 2000, 22:8–18.PubMedCrossRefGoogle Scholar
  18. 18.
    Dale RC, Church AJ, Cardoso F, et al.: Poststreptococcal acute disseminated encephalomyelitis with basal ganglia involvement and auto-reactive antibasal ganglia antibodies. Ann Neurol 2001, 50:588–595. The authors identify a subgroup of pediatric post-streptococcal acute disseminated encephalomyelitis with prominent extrapyramidal and behavioral signs and specific autoantibodies.PubMedCrossRefGoogle Scholar
  19. 19.
    Ziegler DK: Acute disseminated encephalitis: some diagnostic and therapeutic considerations. Arch Neurol 1966, 14:476–488.PubMedGoogle Scholar
  20. 20.
    Atlas SW, Grossman RK, Goldberg HI, et al.: Diagnosis of acute disseminated encephalomyelitis. J Comput Assist Tomogr 1986, 10:798–801.PubMedCrossRefGoogle Scholar
  21. 21.
    Kanter DS, Horensky D, Sperling RA, et al.: Plasmapheresis in fulminant acute disseminated encephalomyelitis. Neurology 1995, 45:824–827.PubMedGoogle Scholar
  22. 22.
    Modi G, Mochan A, Modi M, Saffer D: Demyelinating disorder of the central nervous system occurring in black South Africans. J Neurol Neurosurg Psychiatry 2001, 70:500–505. These eight cases demonstrate features of neuromyelitis optica, acute disseminated encephalomyelitis, and multiple sclerosis, highlighting the challenges faced in classification of central nervous system demyelinating syndromes.PubMedCrossRefGoogle Scholar
  23. 23.
    Murray BJ, Apetauerova D, Scammell TE: Severe acute disseminated encephalomyelitis with normal MRI at presentation. Neurology 2000, 55:1237–1238.PubMedGoogle Scholar
  24. 24.
    Honkaniemi J, Dastidar P, Kähärä V, Haapasalo H: Delayed MR imaging changes in acute disseminated encephalomyelitis. Am J Neuroradiol 2001, 22:1117–1124.PubMedGoogle Scholar
  25. 25.
    Baum PA, Barkovich AJ, Koch TK, Berg BO: Deep gray matter involvement in children with acute disseminated encephalomyelitis. Am J Neuroradiol 1994, 15:1275–1283.PubMedGoogle Scholar
  26. 26.
    Olivero WC, Deshmukh P, Gujrati M: Bilateral enhancing thalamic lesions in a 10 year old boy: case report. J Neurol Neurosurg Psychiatry 1999, 66:633–635.PubMedGoogle Scholar
  27. 27.
    Hamed LM, Silbiger J, Guy J, et al.: Parainfectious optic neuritis and encephalomyelitis. A report of two cases with thalamic involvment. J Clin Neuro-ophthalmol 1993, 13:18–23.Google Scholar
  28. 28.
    Miller DH, Scaravilli F, Thomas DC, et al.: Acute disseminated encephalomyelitis presenting as a solitary brainstem mass. J Neurol Neurosurg Psychiatry 1993, 56:920–922.PubMedGoogle Scholar
  29. 29.
    De Recondo A, Guichard JP: Acute disseminated encephalomyelitis presenting as multiple cystic lesions. J Neurol Neurosurg Psychiatry 1997, 63:15.PubMedGoogle Scholar
  30. 30.
    van der Meyden CH, de Villiers JF, Middlecote BD, Terblanchè J: Gadolinium ring enhancement and mass effect in acute disseminated encephalomyelitis. Neuroradiol 1994, 36:221–223.CrossRefGoogle Scholar
  31. 31.
    Bizzi A, Ulug AM, Crawford TO, et al.: Quantitative proton MR spectroscopic imaging in acute disseminated encephalomyelitis. Am J Neuroradiol 2001, 22:1125–1130.PubMedGoogle Scholar
  32. 32.
    Harada M, Hisaoka S, Mori K, et al.: Differences in water diffusion and lactate production in two different types of postinfectious encephalopathy. J Mag Res Imag 2000, 11:559–563.CrossRefGoogle Scholar
  33. 33.
    Bernarding J, Braun J, Koennecke H-C: Diffusion- and perfusion-weighted MR imaging in a patient with acute disseminated encephalomyelitis (ADEM). J Mag Res Imag 2002, 15:96–100.CrossRefGoogle Scholar
  34. 34.
    Tan TX, Spigos DG, Mueller CF: Abnormal cortical metabolism in acute disseminated encephalomyelitis. Clin Nucl Med 1998, 23:629–630.PubMedCrossRefGoogle Scholar
  35. 35.
    Itti E, Huff K, Cornford ME, et al.: Postinfectious encephalitis. A coregistered SPECT and magnetic resonance imaging study. Clin Nucl Med 2002, 27:129–130.PubMedCrossRefGoogle Scholar
  36. 36.
    Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG: Multiple sclerosis. N Engl J Med 2000, 343:938–952.PubMedCrossRefGoogle Scholar
  37. 37.
    Jacobs LD, Beck RW, Simon JH, et al.: Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med 2000, 343:898–904.PubMedCrossRefGoogle Scholar
  38. 38.
    Comi G, Filippi M, Barkhof F, et al.: Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 2001, 357:1576–1582.PubMedCrossRefGoogle Scholar
  39. 39.
    O’Riordan JI, Gomez-Anson B, Moseley IF, Miller DH: Long term MRI follow-up of patients with post infectious encephalomyelitis: evidence for a monophasic disease. J Neurol Sci 1999, 167:132–136.PubMedCrossRefGoogle Scholar
  40. 40.
    McDonald WI, Compston A, Edan G, et al.: Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001, 50:121–127. These new diagnostic recommendations integrate magnetic resonance imaging (MRI) findings and specifically suggest that new MRI lesions occurring after a 3-month interval following the first attack may differentiate acute disseminated encephalomyelitis from multiple sclerosis.PubMedCrossRefGoogle Scholar
  41. 41.
    Miller HG, Evans MJ: Prognosis in acute disseminated encephalomyelitis; with a note on neuromyelitis optica. Q J Med 1953, 22:347–349.PubMedGoogle Scholar
  42. 42.
    Durston JH, Milnes JN: Relapsing encephalomyelitis. Brain 1970, 93:715–730.PubMedCrossRefGoogle Scholar
  43. 43.
    Cohen O, Steiner-Birmanns B, Biran I, et al.: Recurrence of acute disseminated encephalomyelitis at the previously affected brain site. Arch Neurol 2001, 58:797–801.PubMedCrossRefGoogle Scholar
  44. 44.
    Straub J, Chofflon M, Delavelle J: Early high-dose intravenous methylprednisolone in acute disseminated encephalomyelitis: a successful recovery. Neurology 1997, 49:1145–1147.PubMedGoogle Scholar
  45. 45.
    Weinshenker BG, O’Brien PC, Petterson TM, et al.: A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 1999, 46:878–886.PubMedCrossRefGoogle Scholar
  46. 46.
    Rodriguez M, Karnes WE, Bartleson JD, Pineda AA: Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination. Neurology 1993, 43:1100–1104.PubMedGoogle Scholar
  47. 47.
    Miyazawa R, Hikima A, Takano Y, et al.: Plasmapheresis in fulminant acute disseminated encephalomyelitis. Brain Dev 2001, 23:424–426.PubMedCrossRefGoogle Scholar
  48. 48.
    Kleiman M, Brunquell P: Acute disseminated encephalomyelitis: response to intravenous immunoglobulin? J Child Neurol 1995, 10:481–483.PubMedGoogle Scholar
  49. 49.
    Hahn JS, Siegler DJ, Enzmann D: Intravenous gammaglobulin therapy in recurrent acute disseminated encephalomyelitis. Neurology 1996, 46:1173–1174.PubMedGoogle Scholar
  50. 50.
    Pradhan S, Gupta RP, Shashank S, Pandey N: Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. J Neurol Sci 1999, 165:56–61.PubMedCrossRefGoogle Scholar
  51. 51.
    Sahlas DJ, Miller SP, Guerin M, et al.: Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin. Neurology 2000, 54:1370–1372.PubMedGoogle Scholar
  52. 52.
    Marchioni E, Marinou-Aktipi K, Uggetti C, et al.: Effectiveness of intravenous immunoglobulin treatment in adult patients with steroid-resistant monophasic or recurrent acute disseminated encephalomyelitis. J Neurol 2002, 249:100–104.PubMedCrossRefGoogle Scholar
  53. 53.
    Takata T, Hirakawa M, Sakurai M, Kanazawa I: Fulminant form of acute disseminated encephalomyelitis: successful treatment with hypothermia. J Neurol Sci 1999, 165:94–97.PubMedCrossRefGoogle Scholar
  54. 54.
    Gold R, Hartung H-P, Toyka KV: Animal models for autoimmune demyelinating disorders of the nervous system. Mol Med Today 2000, 6:88–91.PubMedCrossRefGoogle Scholar
  55. 55.
    Ben-Nun A, Wekerle H, Cohen IR: The rapid isolation of clonable antigen specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol 1981, 11:195–199.PubMedCrossRefGoogle Scholar
  56. 56.
    Kuchroo VK, Sobel RA, Yamamura T, et al.: Induction of experimental allergic encephalomyelitis by myelin proteolipidprotein-specific T cell clones and synthetic peptides. Pathobiology 1991, 59:305–312.PubMedGoogle Scholar
  57. 57.
    Linington C, Engelhardt B, Kapocs G, Lassman H: Induction of persistently demyelinated lesions in the rate following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody. J Neuroimmunol 1992, 40:219–242.PubMedCrossRefGoogle Scholar
  58. 58.
    Miller SD, Vanderlugt CL, Begolka WS, et al.: Persistent infection with Theiler’s virus leads to autoimmunity via epitope spreading. Nat Med 1997, 3:1133–1136.PubMedCrossRefGoogle Scholar
  59. 59.
    Racke MK, Quigley L, Cannella B, et al.: Superantigen modulation of experimental allergic encephalomyelitis: activation of anergy determines outcome. J Immunol 1994, 152:2051–2059.PubMedGoogle Scholar
  60. 60.
    Eugster HP, Frei K, Winkler F, et al.: Superantigen overcomes resistance of IL-6-deficient mice towards MOG-induced EAE by a TNFR1 controlled pathway. Eur J Immunol 2001, 31:2302–2312.PubMedCrossRefGoogle Scholar
  61. 61.
    Jorens PG, VanderBorght A, Ceulemans B, et al.: Encephalomyelitis-associated antimyelin autoreactivity induced by streptococcal exotoxins. Neurology 2000, 54:1433–1441.PubMedGoogle Scholar
  62. 62.
    Wingerchuk DM, Lucchinetti CF, Noseworthy JH: Multiple sclerosis: current pathophysiological concepts. Lab Invest 2001, 81:263–281.PubMedGoogle Scholar
  63. 63.
    Ichiyama T, Shoji H, Kato M, et al.: Cerebrospinal fluid levels of cytokines and soluble tumour necrosis factor receptor in acute disseminated encephalomyelitis. Eur J Pediatr 2002, 161:133–137.PubMedCrossRefGoogle Scholar
  64. 64.
    Bauer J, Stadelmann C, Bancher C, et al.: Apoptosis of T lymphocytes in acute disseminated encephalomyelitis. Acta Neuropathol 1999, 97:543–546.PubMedCrossRefGoogle Scholar
  65. 65.
    Laouini D, Kennou MF, Khoufi S, Dellagi K: Antibodies to human myelin proteins and gangliosides in patients with acute neuroparalytic accidents induced by brain-derived rabies vaccine. J Neuroimmunol 1998, 91:63–72.PubMedCrossRefGoogle Scholar
  66. 66.
    Pohl-Koppe A, Burchett SK, Thiele EA, Hafler DA: Myelin basic protein reactive Th2 T cells are found in acute disseminated encephalomyelitis. J Neuroimmunol 1998, 19–27.Google Scholar
  67. 67.
    Lucchinetti CF, Mandler RN, McGavern D, et al.: A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica. Brain 2002, 125:1450–1461. The authors describe immunopathologic evidence for humoral immune mechanisms in neuromyelitis optica.PubMedCrossRefGoogle Scholar
  68. 68.
    Transverse Myelitis Consortium Working Group: Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2002, 59:499–505. This paper is an effort towards consensus and standardization in the study of acute transverse myelitis.Google Scholar
  69. 69.
    Mandler RN, Davis LE, Jeffery DR, Kornfeld M: Devic’s neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 1993, 34:162–168.PubMedCrossRefGoogle Scholar
  70. 70.
    O’Riordan JI, Gallagher HL, Thompson AJ, et al.: Clinical, CSF, and MRI findings in Devic’s neuromyelitis optica. J Neurol Neurosurg Psychiatr 1996, 60:382–387.PubMedCrossRefGoogle Scholar
  71. 71.
    Wingerchuk DM, Hogancamp WH, O’Brien PC, Weinshenker BG: The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology 1999, 53:1107–1114.PubMedGoogle Scholar

Copyright information

© Current Science Inc 2003

Authors and Affiliations

  • Dean M. Wingerchuk
    • 1
  1. 1.Department of NeurologyMayo ClinicScottsdaleUSA

Personalised recommendations